Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2009-03-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Carbohydrates in Irritable Bowel Syndrome
NCT04830410
Effect of a Probiotic, Lactobacillus FARCIMINIS, in Diarrhea Predominant IBS Patients
NCT00561535
Brain and Gut Responses to Intragastric Administration of FODMAPs in Healthy Subjects and Patients With Irritable Bowel Syndrome
NCT04283487
Biomarkers of Diet-microbiota Interactions in Irritable Bowel Syndrome
NCT04364750
To Study the Effect of Short-chain Fructooligosaccharides in Women With Irritable Bowel Syndrome
NCT05941650
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Fructo-oligosaccharides
Fructo-oligosaccharides
Dietary supplementation for 4 weeks
2
Maltodextrins
Maltodextrins
Dietary supplementation for 4 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fructo-oligosaccharides
Dietary supplementation for 4 weeks
Maltodextrins
Dietary supplementation for 4 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Incomfort below or equivalent to 30mmHg during Tensostat test
* between 18 and 60 years
* no antibiotic treatment for the last 2 months
* less than 20g of dietary fibres consummed per day
* no analgesic treatment
* no treatment for intestinal transit
Exclusion Criteria
* excessive consumption of alcohol or tobacco
* participating to another clinical study
* pregnant women
* antidepressor or anxiolytic treatment
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beghin-Meiji
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Beghin Meiji
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michel Dapoigny, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Clermont-Ferrand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Clermont Ferrand
Clermont-Ferrand, , France
Vall Hebron Hospital
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FOS_QLV2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.